Polymorphic forms α, β and γ of rifaximin | Patent Number 07902206

US 07902206 B2
Application Number12119600
Publication NumberUS 20080262220 A1
Pendency2 years, 9 months, 29 days
Filled DateMay 13, 2008
Priority DateNov 4, 2004
Publication DateOct 23, 2008
Expiration DateNov 4, 2024
Inventor/ApplicantsDario Braga
Giuseppe Claudio Viscomi
Donatella Confortini
Paolo Righi
Goffredo Rosini
Manuela Campana
Vincenzo Cannata
ExaminesKIFLE, BRUCK
Art Unit1624
Technology Center1600
Assignments
Alfasigma S.p.a.
Current
Alfa Wassermann S.p.a.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.